• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度致病性铜绿假单胞菌抗菌药物耐药性决定因素的遗传多样性

Genetic Diversity in Antimicrobial Resistance Determinants Among Pathogenic Pseudomonas aeruginosa in India.

作者信息

Rathod Milan, Shukla Suraj, Sanapala Paparaidu, Rajni Ekadashi, Maheshwari Geeti, Gajjar Devarshi

机构信息

Department of Microbiology and Biotechnology Centre, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, 390002, India.

Department of Microbiology, Mahatma Gandhi University of Medical Sciences and Technology, Jaipur, Rajasthan, 302022, India.

出版信息

Curr Microbiol. 2025 Mar 13;82(5):189. doi: 10.1007/s00284-025-04174-5.

DOI:10.1007/s00284-025-04174-5
PMID:40080202
Abstract

The drastic rise in antibiotic resistance has become a global challenge, including India, due to high morbidity. The delayed identification and lack of treatment are the major causes of death. However, there is a shortage of precise information on the specific resistance pattern and sequence types of Pseudomonas aeruginosa from India that can help in diagnostics and therapy. A total of 16 clinical isolates were collected from the western region of India, along with 181 P. aeruginosa genomes of India from public database were retrieved and thoroughly analysed for antibiotics resistance determinants for associated sequence types and O-serotypes using different bioinformatics tools. Of all collected isolates (n = 16), 9 were extensively drug-resistant (XDR), 6 were multidrug-resistant (MDR), and only 1 isolate was susceptible to selected antibiotics. ST357 (n = 23; 11.6%) was the most frequent, followed by ST308, and ST1203. In serotyping, O11 (n = 85; 43%) was most prevalent. A novel ST4937 was reported and submitted to PubMLST. bla carbapenemase was found in (n = 45; 22.8%) isolates, whereas class D bla was present in (n = 38; 19.2%) isolates, further, several variants were found for class C bla genes, where bla and bla were found to be predominant. We discovered that the amounts of carbapenemases and extended spectrum beta-lactamases (ESBL) genes were lower in India. This can be a relief sometimes, but a rise in high-risk clones could lead to longer hospital stays and more deaths. Therefore, ongoing surveillance of these strains is essential for effective infection management and containment of their spread.

摘要

由于发病率高,抗生素耐药性的急剧上升已成为包括印度在内的全球挑战。诊断延误和缺乏治疗是主要死因。然而,关于印度铜绿假单胞菌的特定耐药模式和序列类型,缺乏能有助于诊断和治疗的精确信息。从印度西部地区共收集了16株临床分离株,同时从公共数据库中检索了181个印度铜绿假单胞菌基因组,并使用不同的生物信息学工具对相关序列类型和O血清型的抗生素耐药决定因素进行了全面分析。在所有收集的分离株(n = 16)中,9株为广泛耐药(XDR),6株为多重耐药(MDR),只有1株对选定抗生素敏感。ST357(n = 23;11.6%)最为常见,其次是ST308和ST1203。在血清分型中,O11(n = 85;43%)最为普遍。报告了一个新的ST4937并提交至PubMLST。在(n = 45;22.8%)的分离株中发现了bla碳青霉烯酶,而D类bla存在于(n = 38;19.2%)的分离株中,此外,还发现了C类bla基因的几个变体,其中bla和bla占主导地位。我们发现印度碳青霉烯酶和超广谱β-内酰胺酶(ESBL)基因的数量较少。这有时可能是一种缓解,但高风险克隆的增加可能导致住院时间延长和更多死亡。因此,持续监测这些菌株对于有效管理感染和控制其传播至关重要。

相似文献

1
Genetic Diversity in Antimicrobial Resistance Determinants Among Pathogenic Pseudomonas aeruginosa in India.印度致病性铜绿假单胞菌抗菌药物耐药性决定因素的遗传多样性
Curr Microbiol. 2025 Mar 13;82(5):189. doi: 10.1007/s00284-025-04174-5.
2
Import of global high-risk clones is the primary driver of carbapenemase-producing in Norway.全球高危克隆株的引入是挪威产碳青霉烯酶菌株产生的主要驱动因素。
J Med Microbiol. 2025 Jan;74(1). doi: 10.1099/jmm.0.001944.
3
Dominance of international high-risk clones in carbapenemase-producing : Multicentric molecular epidemiology report from India.产碳青霉烯酶菌中国际高风险克隆的优势:来自印度的多中心分子流行病学报告
Indian J Med Microbiol. 2018 Jul-Sep;36(3):344-351. doi: 10.4103/ijmm.IJMM_18_294.
4
Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update.铜绿假单胞菌流行高危克隆及其与水平获得性β-内酰胺酶的关系:2020 年更新。
Int J Antimicrob Agents. 2020 Dec;56(6):106196. doi: 10.1016/j.ijantimicag.2020.106196. Epub 2020 Oct 9.
5
Characterization and genetic analysis of extensively drug-resistant hospital acquired Pseudomonas aeruginosa isolates.广泛耐药医院获得性铜绿假单胞菌分离株的特征和遗传分析。
BMC Microbiol. 2024 Jun 26;24(1):225. doi: 10.1186/s12866-024-03321-5.
6
Genome analysis of extensively drug-resistant Pseudomonas aeruginosa ST1971 from a patient in China hospitalized for severe pneumonia.中国一重症肺炎住院患者携带的广泛耐药铜绿假单胞菌 ST1971 的基因组分析。
J Glob Antimicrob Resist. 2024 Sep;38:123-127. doi: 10.1016/j.jgar.2024.04.002. Epub 2024 May 9.
7
Genetic characteristics and diversity of PDC variants of Pseudomonas aeruginosa and its clinical relevance.铜绿假单胞菌PDC变体的遗传特征、多样性及其临床相关性。
Infect Genet Evol. 2024 Dec;126:105701. doi: 10.1016/j.meegid.2024.105701. Epub 2024 Dec 7.
8
Genome analyses of colistin-resistant high-risk bla producing Klebsiella pneumoniae ST147 and Pseudomonas aeruginosa ST235 and ST357 in clinical settings.临床环境中产高风险 bla 碳青霉烯酶的耐药肺炎克雷伯菌 ST147 和铜绿假单胞菌 ST235 和 ST357 的基因组分析。
BMC Microbiol. 2024 May 20;24(1):174. doi: 10.1186/s12866-024-03306-4.
9
Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital.土耳其产碳青霉烯酶铜绿假单胞菌分离株:三级医院中发现具有 VIM-5 和 IMP-7 型碳青霉烯酶的高风险克隆的铜绿假单胞菌的首次报告。
Diagn Microbiol Infect Dis. 2021 Jan;99(1):115174. doi: 10.1016/j.diagmicrobio.2020.115174. Epub 2020 Aug 12.
10
Resistance to ceftazidime-avibactam and other new β-lactams in clinical isolates: a multi-center surveillance study.临床分离株对头孢他啶-阿维巴坦及其他新型β-内酰胺类药物的耐药性:一项多中心监测研究。
Microbiol Spectr. 2024 Aug 6;12(8):e0426623. doi: 10.1128/spectrum.04266-23. Epub 2024 Jun 27.

本文引用的文献

1
Genomics of Aminoglycoside Resistance in Pseudomonas aeruginosa Bloodstream Infections at a United States Academic Hospital.铜绿假单胞菌血流感染中氨基糖苷类耐药基因的研究-美国某学术医院报告
Microbiol Spectr. 2023 Jun 15;11(3):e0508722. doi: 10.1128/spectrum.05087-22. Epub 2023 May 16.
2
Introducing the Bacterial and Viral Bioinformatics Resource Center (BV-BRC): a resource combining PATRIC, IRD and ViPR.推出细菌和病毒生物信息学资源中心(BV-BRC):一个整合 PATRIC、IRD 和 ViPR 的资源。
Nucleic Acids Res. 2023 Jan 6;51(D1):D678-D689. doi: 10.1093/nar/gkac1003.
3
Aminoglycoside-Modifying Enzymes Are Sufficient to Make Clinically Resistant to Key Antibiotics.
氨基糖苷类修饰酶足以使临床菌株对关键抗生素产生耐药性。
Antibiotics (Basel). 2022 Jul 1;11(7):884. doi: 10.3390/antibiotics11070884.
4
Association of sequence types, antimicrobial resistance and virulence genes in Indian isolates of Klebsiella pneumoniae: A comparative genomics study.印度肺炎克雷伯菌分离株的序列型、抗菌药物耐药性和毒力基因的相关性:比较基因组学研究。
J Glob Antimicrob Resist. 2022 Sep;30:431-441. doi: 10.1016/j.jgar.2022.05.006. Epub 2022 May 13.
5
Localized outbreaks of belonging to international high-risk clones in a south Indian hospital.在一家印度南部医院,属于国际高风险克隆的地方性暴发。
J Med Microbiol. 2022 Mar;71(3). doi: 10.1099/jmm.0.001500.
6
Carbapenemase-producing -an emerging challenge.产碳青霉烯酶 - 新出现的挑战。
Emerg Microbes Infect. 2022 Dec;11(1):811-814. doi: 10.1080/22221751.2022.2048972.
7
Complete genome sequence of an extensively drug-resistant Pseudomonas aeruginosa ST773 clinical isolate from North India.一株广泛耐药铜绿假单胞菌 ST773 临床分离株的全基因组序列,该菌分离自印度北部。
J Glob Antimicrob Resist. 2021 Dec;27:244-246. doi: 10.1016/j.jgar.2021.10.010. Epub 2021 Oct 26.
8
Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa and Impact of Antimicrobial Resistance and Bacterial Virulence.铜绿假单胞菌血流感染的死亡率预测因子及抗菌药物耐药性和细菌毒力的影响。
Antimicrob Agents Chemother. 2020 Jan 27;64(2). doi: 10.1128/AAC.01759-19.
9
Association between Pseudomonas aeruginosa O-antigen serotypes, resistance profiles and high-risk clones: results from a Spanish nationwide survey.铜绿假单胞菌 O 抗原血清型、耐药谱与高危克隆之间的关联:来自西班牙全国性调查的结果。
J Antimicrob Chemother. 2019 Nov 1;74(11):3217-3220. doi: 10.1093/jac/dkz346.
10
Diversity of carbapenemases in clinical isolates: The emergence of bla in Bangladesh.临床分离株中碳青霉烯酶的多样性:孟加拉国bla的出现。
J Infect Chemother. 2019 Jun;25(6):444-451. doi: 10.1016/j.jiac.2019.01.010. Epub 2019 Feb 26.